Enhabit (EHAB) Stock Forecast, Price Target & Predictions
EHAB Stock Forecast
Enhabit stock forecast is as follows: an average price target of $9.50 (represents a 24.18% upside from EHAB’s last price of $7.65) and a rating consensus of 'Hold', based on 5 wall street analysts offering a 1-year stock forecast.
EHAB Price Target
The average price target for Enhabit (EHAB) is $9.50 based on 1-year price targets from 5 Wall Street analysts in the past 3 months, with a price target range of $9.50 to $9.50. This represents a potential 24.18% upside from EHAB's last price of $7.65.
EHAB Analyst Ratings
According to 5 Wall Street analysts, Enhabit's rating consensus is 'Hold'. The analyst rating breakdown for EHAB stock is 0 'Strong Buy' (0.00%), 0 'Buy' (0.00%), 5 'Hold' (100.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Enhabit Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Dec 09, 2024 | Brian Tanquilut | Jefferies | $9.50 | $7.73 | 22.90% | 24.18% |
| May 14, 2024 | Whit Mayo | Leerink Partners | $8.50 | $8.64 | -1.62% | 11.11% |
| Dec 08, 2022 | UBS | $12.00 | $13.99 | -14.22% | 56.86% |
The latest Enhabit stock forecast, released on Dec 09, 2024 by Brian Tanquilut from Jefferies, set a price target of $9.50, which represents a 22.90% increase from the stock price at the time of the forecast ($7.73), and a 24.18% increase from EHAB last price ($7.65).
Enhabit Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 1 | 2 |
| Avg Price Target | $9.50 | $9.50 | $9.00 |
| Last Closing Price | $7.65 | $7.65 | $7.65 |
| Upside/Downside | 24.18% | 24.18% | 17.65% |
In the current month, the average price target of Enhabit stock is $9.50, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 24.18% increase as opposed to Enhabit's last price of $7.65. This month's average price target is down 0.00% compared to last quarter, and up 5.56% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| May 14, 2024 | Leerink Partners | Market Perform | Upgrade | |
| May 09, 2024 | Jefferies | Hold | Downgrade | |
| Mar 07, 2024 | UBS | Sell | Neutral | Upgrade |
| Aug 11, 2023 | Credit Suisse | Neutral | Neutral | Hold |
| Dec 13, 2022 | CJS Securities | Market Perform | Initialise | |
| Dec 08, 2022 | UBS | Sell | Initialise | |
| Oct 13, 2022 | Oppenheimer | Perform | Initialise |
Enhabit's last stock rating was published by Leerink Partners on May 14, 2024. The company Upgrade its EHAB rating from "null" to "Market Perform".
Enhabit Financial Forecast
Enhabit Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $260.60M | $258.30M | - | $265.10M | $275.10M | $265.70M | $268.00M |
| Avg Forecast | $283.43M | $288.95M | $272.78M | $273.45M | $273.04M | $268.31M | $265.85M | $266.17M | $259.11M | $261.60M | $267.33M | $268.45M | $260.16M | $265.32M | $273.51M | $271.45M | $267.86M | $266.45M | $268.18M |
| High Forecast | $291.05M | $296.72M | $280.11M | $280.80M | $280.38M | $275.52M | $272.99M | $275.61M | $262.84M | $262.09M | $267.33M | $268.45M | $263.76M | $265.39M | $280.87M | $278.75M | $275.06M | $266.45M | $268.18M |
| Low Forecast | $274.99M | $280.34M | $264.65M | $265.31M | $264.91M | $260.31M | $257.93M | $256.72M | $255.66M | $261.11M | $267.33M | $268.45M | $257.29M | $265.26M | $265.37M | $263.36M | $259.88M | $266.45M | $268.18M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 4 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 4 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 0.97% | - | 0.98% | 1.03% | 1.00% | 1.00% |
Enhabit's average Quarter revenue forecast for Mar 24 based on 3 analysts is $268.45M, with a low forecast of $268.45M, and a high forecast of $268.45M. EHAB's average Quarter revenue forecast represents a 3.01% increase compared to the company's last Quarter revenue of $260.60M (Dec 23).
Enhabit EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 4 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 4 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $12.60M | $15.60M | - | $22.00M | $36.80M | $25.90M | $35.50M |
| Avg Forecast | $22.61M | $23.05M | $21.76M | $21.82M | $21.78M | $21.40M | $21.21M | $21.23M | $20.67M | $20.87M | $21.33M | $21.42M | $20.75M | $21.17M | $21.82M | $21.66M | $21.37M | $31.50M | $163.30M |
| High Forecast | $23.22M | $23.67M | $22.35M | $22.40M | $22.37M | $21.98M | $21.78M | $21.99M | $20.97M | $20.91M | $21.33M | $21.42M | $21.04M | $21.17M | $22.41M | $22.24M | $21.94M | $31.50M | $195.96M |
| Low Forecast | $21.94M | $22.37M | $21.11M | $21.17M | $21.13M | $20.77M | $20.58M | $20.48M | $20.40M | $20.83M | $21.33M | $21.42M | $20.53M | $21.16M | $21.17M | $21.01M | $20.73M | $31.50M | $130.64M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.61% | 0.74% | - | 1.02% | 1.72% | 0.82% | 0.22% |
3 analysts predict EHAB's average Quarter EBITDA for Mar 24 to be $21.42M, with a high of $21.42M and a low of $21.42M. This is 69.97% upper than Enhabit's previous annual EBITDA (Dec 23) of $12.60M.
Enhabit Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 4 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 4 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-6.40M | $-2.40M | - | $2.70M | $7.70M | $8.60M | $20.10M |
| Avg Forecast | $3.60M | $7.75M | $5.38M | $5.27M | $3.81M | $2.34M | $3.18M | $3.14M | $2.72M | $1.97M | $2.86M | $2.33M | $1.27M | $3.05M | $6.77M | $7.72M | $11.67M | $14.50M | $20.92M |
| High Forecast | $3.73M | $8.03M | $5.57M | $5.46M | $3.94M | $2.42M | $3.29M | $3.76M | $3.81M | $2.04M | $2.86M | $2.34M | $1.29M | $3.16M | $7.00M | $7.99M | $12.08M | $14.50M | $25.10M |
| Low Forecast | $3.46M | $7.45M | $5.17M | $5.07M | $3.66M | $2.25M | $3.05M | $1.88M | $2.18M | $1.89M | $2.86M | $2.32M | $1.25M | $2.93M | $6.51M | $7.42M | $11.22M | $14.50M | $16.74M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -5.06% | -0.79% | - | 0.35% | 0.66% | 0.59% | 0.96% |
Enhabit's average Quarter net income forecast for Jun 23 is $6.77M, with a range of $6.51M to $7.00M. EHAB's average Quarter net income forecast represents a 150.67% increase compared to the company's last Quarter net income of $2.70M (Mar 23).
Enhabit SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 4 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 4 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $114.50M | $108.80M | - | $110.50M | $106.50M | $107.50M | $102.20M |
| Avg Forecast | $112.00M | $114.18M | $107.78M | $108.05M | $107.89M | $106.02M | $105.05M | $105.17M | $102.39M | $103.37M | $105.63M | $106.07M | $102.80M | $104.84M | $108.08M | $107.26M | $105.84M | $105.29M | $106.37M |
| High Forecast | $115.01M | $117.25M | $110.68M | $110.96M | $110.79M | $108.87M | $107.87M | $108.90M | $103.86M | $103.56M | $105.63M | $106.07M | $104.22M | $104.87M | $110.98M | $110.14M | $108.69M | $105.29M | $127.65M |
| Low Forecast | $108.66M | $110.78M | $104.57M | $104.83M | $104.68M | $102.86M | $101.92M | $101.44M | $101.02M | $103.17M | $105.63M | $106.07M | $101.67M | $104.81M | $104.86M | $104.07M | $102.69M | $105.29M | $85.10M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.11% | 1.04% | - | 1.03% | 1.01% | 1.02% | 0.96% |
Enhabit's average Quarter SG&A projection for Mar 24 is $106.07M, based on 3 Wall Street analysts, with a range of $106.07M to $106.07M. The forecast indicates a -7.36% fall compared to EHAB last annual SG&A of $114.50M (Dec 23).
Enhabit EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 4 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 4 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.13 | $-0.05 | - | $0.05 | $0.15 | $0.17 | $0.41 |
| Avg Forecast | $0.07 | $0.15 | $0.11 | $0.11 | $0.08 | $0.05 | $0.06 | $0.06 | $0.05 | $0.04 | $0.06 | $0.05 | $0.03 | $0.06 | $0.13 | $0.15 | $0.23 | $0.29 | $0.49 |
| High Forecast | $0.07 | $0.16 | $0.11 | $0.11 | $0.08 | $0.05 | $0.07 | $0.07 | $0.08 | $0.04 | $0.06 | $0.05 | $0.03 | $0.06 | $0.14 | $0.16 | $0.24 | $0.29 | $0.49 |
| Low Forecast | $0.07 | $0.15 | $0.10 | $0.10 | $0.07 | $0.04 | $0.06 | $0.04 | $0.04 | $0.04 | $0.06 | $0.05 | $0.02 | $0.06 | $0.13 | $0.15 | $0.22 | $0.29 | $0.49 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -5.15% | -0.79% | - | 0.33% | 0.65% | 0.59% | 0.84% |
According to 3 Wall Street analysts, Enhabit's projected average Quarter EPS for Jun 23 is $0.13, with a low estimate of $0.13 and a high estimate of $0.14. This represents a 169.64% increase compared to EHAB previous annual EPS of $0.05 (Mar 23).
Enhabit Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| SEM | Select Medical | $19.12 | $40.00 | 109.21% | Buy |
| ACHC | Acadia Healthcare Company | $39.64 | $81.50 | 105.60% | Buy |
| INNV | InnovAge | $4.08 | $6.80 | 66.67% | Hold |
| PNTG | Pennant Group | $29.21 | $34.67 | 18.69% | Buy |
| HCSG | Healthcare Services Group | $11.80 | $14.00 | 18.64% | Hold |
| EHAB | Enhabit | $8.29 | $9.50 | 14.60% | Hold |
| ENSG | Ensign Group | $140.00 | $159.00 | 13.57% | Buy |
| ADUS | Addus HomeCare | $130.73 | $146.20 | 11.83% | Buy |
| EHC | Encompass Health | $96.94 | $107.50 | 10.89% | Buy |